Danmarks Skibskredit A/S
10.3.2021 12:04:34 CET | Globenewswire | Press release
New Final Bond Terms for the Danish Ship Finance A/S Base Prospectus dated 9 July 2020
Danish Ship Finance issues new floating rate non-callable bullet bond (SMB) with maturity date 1 January 2029.
In connection with the opening of new ISINs under the Danish Ship Finance A/S Base Prospectus dated 9 July 2020, Danish Ship Finance issues new Final Bond Terms.
The Final Bond Terms are stated below.
The Danish Ship Finance A/S Base Prospectus dated 9 July 2020 and the relevant Final Bond Terms are available for download on Danish Ship Finance A/S’ website at http://www.shipfinance.dk/investor-relations/.
| ISIN | Capital Centre | Currency | Opening date | Maturity |
| DK0004133055 | Institute in General | DKK | 12 March 2021 | 1 January 2029 |
Questions may be addressed to Head of Funding, Casper Fries, tel +45 33 33 93 33, IR@skibskredit.dk
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
CoinShares International Limited18.3.2026 08:00:00 CET | Press release
CoinShares Leverages Railnet to Launch On-Chain Asset Management Strategy Combining DeFi and Tokenised Real-World Asset Yields
Zero Hash18.3.2026 07:15:00 CET | Press release
zerohash Expands European Headquarters in Amsterdam to Support EU Growth
Bitget Limited18.3.2026 07:10:49 CET | Press release
Bitget Invites Affiliates to Split "The Missing 40%" Revenue Plus $1 Million USDT Prize Pool
SkiStar AB18.3.2026 07:00:00 CET | Press release
SkiStar AB half-year report September 2025-February 2026
Sanofi Winthrop Industrie18.3.2026 07:00:00 CET | Press release
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
